Purissima (San Francisco, CA) has announced an exclusive, multi-year processing and distribution partnership with Open Book Extracts (OBX, Roxboro, NC). This collaboration also marks Purissima as the first company to achieve commercial scale production of minor cannabinoids using Purissima’s proprietary algae-based fermentation platform, the company stated.

Kicking off production in July 2022, the compounds are proposed to be available to manufacturers and sold to consumer brands before fall 2022.

“This exclusive partnership validates Purissima’s capability to lead the industry forward in unprecedented research, fermentation scalability, and heightened minor cannabinoid access by consumers,” said Robert Evans, Purissima co-founder and chief business and strategy officer. “The partnership with Open Book Extracts will allow our sustainably produced, safe and therapeutic compounds to create a new landscape of cannabinoid-infused products for companies and consumers alike.”

“Open Book Extracts thrives on aligning with companies that propel the cannabinoid industry through technological innovation and science-backed efficacy,” noted Dave Neundorfer, chief executive officer of OBX. “We look forward to working with Purissima to introduce this technology to the market. This partnership is mutually beneficial for the two industry front runners to forge a new path in sustainability and cannabinoid production. Rooted in groundbreaking science and high-quality, safe products.”

George Rudenko, Purissima co-founder, chief executive and chief technology officer added, “Purissima’s multi-patented technology has proven that bioengineering plant-based ingredients and medicinal compounds, such as in the case of minor cannabinoids, is indeed a reality and will provide unparalleled development and amplification of rare and hard to find compounds. Through the commercialization of our first compounds, Open Book Extracts and Purissima can jointly redefine how cannabinoids are sustainably sourced, and their diverse health and wellness applications are realized at commercial scale.”

For more information, visit www.purissima.bio or https://openbookextracts.com.